Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19John C. Marshall, Jonathan A C Sterne, Srinivas Murthy et al.|JAMA|2020Cited by 2.4k
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19Derek C. Angus, Balasubramanian Venkatesh, Marc J. M. Bonten et al.|JAMA|2020Cited by 884
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C. Angus, Steven Webb, Scott Berry et al.|Annals of the American Thoracic Society|2020Cited by 449
Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational studyAlexander Avidan, Spyros D. Mentzelopoulos, Charles L. Sprung et al.|The Lancet Respiratory Medicine|2021Cited by 169
Continuation of therapeutic dose heparin for critically ill patients with COVID-19Charlotte Bradbury, Edward Litton, Patrick R. Lawler et al.|Intensive Care Medicine|2023Cited by 6